Aug 2 (Reuters) - Cytosorbents Corp CTSO.O :
* CYTOSORBENTS REPORTS SECOND QUARTER 2022 FINANCIAL AND
OPERATIONAL RESULTS
* CYTOSORBENTS CORP - TOTAL Q2 2022 REVENUE, INCLUDING
PRODUCT
SALES AND GRANT INCOME, WAS $8.5 MILLION VERSUS $12.0 MILLION
* CYTOSORBENTS CORP - COVID-19 RELATED SALES DURING QUARTER
WERE
NEGLIGIBLE REFLECTING LOW SEVERITY OF CURRENT COVID-19 ILLNESS
* CYTOSORBENTS CORP - DECREASE IN AVERAGE EURO TO U.S.
DOLLAR
EXCHANGE RATE LOWERED Q2 2022 PRODUCT SALES BY ABOUT $840,000
* CYTOSORBENTS CORP - QTRLY NET LOSS PER COMMON SHARE $0.25
Source text for Eikon: ID:nPn6Rtbjja
Further company coverage: CTSO.O
((Reuters.Briefs@thomsonreuters.com;))